Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Period	PE Ratio
2016-04-30	-4.89
2017-04-30	N/A
2018-04-30	N/A
2019-04-30	586.50
2020-04-30	-34.50
2021-04-30	195.50
2022-04-30	146.63
2023-04-30	-15.04
2024-04-30	-10.86
2025-04-30	17.25

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CSBR	$5.87	-2.90%	0.00M
3
4
5

Champions Oncology Inc. (CSBR) PE Ratio

PE Ratio Data

Get Champions Oncology Inc. Data in Excel

More CSBR Financial Data